Progressive well-differentiated metastatic neuroendocrine tumors of the pancreas research hub

A multicenter single-arm pilot study of ramucirumab in combination with dacarbazine in patients with progressive well differentiated metastatic pancreatic neuroendocrine tumors

This study looks at a new treatment called Cyramza combined with a common chemotherapy, dacarbazine, for a specific type of pancreatic cancer that has spread. We want to see if this combination can help control the cancer's growth for at least six months.